Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T.

Eur J Neurol. 2019 Jul 15. doi: 10.1111/ene.14039. [Epub ahead of print]

PMID:
31309642
2.

Olivary hypertrophy improved by steroid treatment: Two case reports with unique presentations.

Ohara M, Sanjo N, Hattori T, Oyama J, Hamada M, Ozaki K, Yokota T.

J Neuroimmunol. 2019 Sep 15;334:577003. doi: 10.1016/j.jneuroim.2019.577003. Epub 2019 Jul 5.

PMID:
31306854
3.

Age at onset in genetic prion disease and the design of preventive clinical trials.

Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S.

Neurology. 2019 Jul 9;93(2):e125-e134. doi: 10.1212/WNL.0000000000007745. Epub 2019 Jun 6.

PMID:
31171647
4.

Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.

Furukawa F, Ishikawa K, Yokota T, Sanjo N.

Eur Neurol. 2019;81(1-2):13-18. doi: 10.1159/000499909. Epub 2019 Apr 23.

PMID:
31013498
5.

Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma.

Hashimoto S, Inaji M, Nariai T, Kobayashi D, Sanjo N, Yokota T, Ishii K, Taketoshi M.

Neurol Med Chir (Tokyo). 2019 May 15;59(5):176-183. doi: 10.2176/nmc.oa.2018-0287. Epub 2019 Apr 17.

6.

Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia.

Amano E, Ozaki K, Ishibashi S, Sanjo N, Yokota T.

J Clin Neurosci. 2019 Apr;62:226-228. doi: 10.1016/j.jocn.2018.12.034. Epub 2019 Jan 3.

PMID:
30612916
7.

A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, Tanizawa T, Yokota T.

J Neurol. 2019 Feb;266(2):369-377. doi: 10.1007/s00415-018-9140-0. Epub 2018 Dec 3.

PMID:
30511098
8.

Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Furukawa F, Sanjo N, Kobayashi A, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Prion. 2018;12(5-6):315-319. doi: 10.1080/19336896.2018.1541689. Epub 2018 Nov 13.

PMID:
30394185
9.

Progressive Encephalomyelitis with Rigidity and Myoclonus Resolving after Thymectomy with Subsequent Anasarca: An Autopsy Case.

Ozaki K, Ohkubo T, Yamada T, Yoshioka K, Ichijo M, Majima T, Kudo S, Akashi T, Honda K, Ito E, Watanabe M, Sekine M, Hamagaki M, Eishi Y, Sanjo N, Ishibashi S, Mizusawa H, Yokota T.

Intern Med. 2018 Dec 1;57(23):3451-3458. doi: 10.2169/internalmedicine.1238-18. Epub 2018 Jul 6.

10.

Brain volume loss is present in Japanese multiple sclerosis patients with no evidence of disease activity.

Yokote H, Kamata T, Toru S, Sanjo N, Yokota T.

Neurol Sci. 2018 Oct;39(10):1713-1716. doi: 10.1007/s10072-018-3487-y. Epub 2018 Jul 4.

PMID:
29974307
11.

Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.

Ito Y, Sanjo N, Hizume M, Kobayashi A, Ohgami T, Satoh K, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1055-1061. doi: 10.1016/j.bbrc.2018.01.119. Epub 2018 Jan 31.

PMID:
29382530
12.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.

Niino M, Fukazawa T, Kira JI, Okuno T, Mori M, Sanjo N, Ohashi T, Fukaura H, Fujimori J, Shimizu Y, Mifune N, Miyazaki Y, Takahashi E, Kikuchi S, Langdon D, Hb Benedict R, Matsui M.

Mult Scler J Exp Transl Clin. 2017 Dec 26;3(4):2055217317748972. doi: 10.1177/2055217317748972. eCollection 2017 Oct-Dec.

13.

Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.

Ohara M, Ozaki K, Ohkubo T, Yamada A, Numasawa Y, Tanaka K, Tomii S, Ishibashi S, Sanjo N, Yokota T.

Intern Med. 2018 Feb 15;57(4):601-604. doi: 10.2169/internalmedicine.9167-17. Epub 2017 Dec 21.

14.

Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis.

Yokote H, Kamata T, Toru S, Sanjo N, Yokota T.

Mult Scler J Exp Transl Clin. 2017 Sep 11;3(3):2055217317729688. doi: 10.1177/2055217317729688. eCollection 2017 Jul-Sep.

15.

Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.

Sato N, Toide N, Kizawa M, Ohkubo T, Ishibashi S, Sanjo N, Yokota T.

J Neurol Sci. 2017 Aug 15;379:219-221. doi: 10.1016/j.jns.2017.06.020. Epub 2017 Jun 15. No abstract available.

PMID:
28716244
16.

Whole-Day Gait Monitoring in Patients with Alzheimer's Disease: A Relationship between Attention and Gait Cycle.

Higuma M, Sanjo N, Mitoma H, Yoneyama M, Yokota T.

J Alzheimers Dis Rep. 2017 Apr 28;1(1):1-8. doi: 10.3233/ADR-170001.

17.

Depressive disorder may be associated with raphe nuclei lesions in patients with brainstem infarction.

Numasawa Y, Hattori T, Ishiai S, Kobayashi Z, Kamata T, Kotera M, Ishibashi S, Sanjo N, Mizusawa H, Yokota T.

J Affect Disord. 2017 Apr 15;213:191-198. doi: 10.1016/j.jad.2017.02.005. Epub 2017 Feb 7.

PMID:
28278447
18.

Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy.

Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki H, Sanjo N, Mizusawa H, Yamada M.

Acta Neuropathol. 2016 Aug;132(2):313-5. doi: 10.1007/s00401-016-1588-3. Epub 2016 Jun 17. No abstract available.

PMID:
27314593
19.

Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment.

Sanjo N, Kina S, Shishido-Hara Y, Nose Y, Ishibashi S, Fukuda T, Maehara T, Eishi Y, Mizusawa H, Yokota T.

Intern Med. 2016;55(12):1631-5. doi: 10.2169/internalmedicine.55.6051. Epub 2016 Jun 15.

20.

[Progressive Multifocal Leukoencephalopathy with Inflammatory Reactions].

Shishido-Hara Y, Uchihara T, Sanjo N.

Brain Nerve. 2016 Apr;68(4):479-88. doi: 10.11477/mf.1416200422. Japanese.

PMID:
27056866
21.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

22.

Ambulatory Gait Behavior in Patients With Dementia: A Comparison With Parkinson's Disease.

Yoneyama M, Mitoma H, Sanjo N, Higuma M, Terashi H, Yokota T.

IEEE Trans Neural Syst Rehabil Eng. 2016 Aug;24(8):817-26. doi: 10.1109/TNSRE.2015.2477856. Epub 2015 Sep 11.

PMID:
26372429
23.

Descriptive epidemiology of prion disease in Japan: 1999-2012.

Nakamaura Y, Ae R, Takumi I, Sanjo N, Kitamoto T, Yamada M, Mizusawa H.

J Epidemiol. 2015;25(1):8-14. doi: 10.2188/jea.JE20140022. Epub 2014 Oct 4.

24.

Serial magnetic resonance imaging changes in sporadic Creutzfeldt-Jakob disease with valine homozygosity at codon 129 of the prion protein gene.

Furukawa F, Ishibashi S, Sanjo N, Yamashita H, Mizusawa H.

JAMA Neurol. 2014 Sep;71(9):1186-7. doi: 10.1001/jamaneurol.2014.548. No abstract available.

PMID:
25070174
25.

Delayed leukoencephalopathy after carbon monoxide poisoning presenting as subacute dementia.

Mizuno Y, Sakurai Y, Sugimoto I, Ichinose K, Ishihara S, Sanjo N, Mizusawa H, Mannen T.

Intern Med. 2014;53(13):1441-5. Epub 2014 Jun 15.

26.

Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene.

Qina T, Sanjo N, Hizume M, Higuma M, Tomita M, Atarashi R, Satoh K, Nozaki I, Hamaguchi T, Nakamura Y, Kobayashi A, Kitamoto T, Murayama S, Murai H, Yamada M, Mizusawa H.

BMJ Open. 2014 May 16;4(5):e004968. doi: 10.1136/bmjopen-2014-004968.

27.

[Review of basic knowledge, surveillance and infectious control of prion disease].

Sanjo N.

Rinsho Shinkeigaku. 2013;23(11):1243-5. Review. Japanese.

PMID:
24291944
28.

Graft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional study.

Sakai K, Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Takumi I, Sanjo N, Nakamura Y, Kitamoto T, Saito N, Mizusawa H, Yamada M.

BMJ Open. 2013 Aug 23;3(8):e003400. doi: 10.1136/bmjopen-2013-003400.

29.

Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura.

Ichijo M, Ishibashi S, Ohkubo T, Nomura S, Sanjo N, Yokota T, Mizusawa H.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):587-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.032. Epub 2013 Jun 6.

PMID:
23747179
30.

Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan.

Hamaguchi T, Sakai K, Noguchi-Shinohara M, Nozaki I, Takumi I, Sanjo N, Sadakane A, Nakamura Y, Kitamoto T, Saito N, Mizusawa H, Yamada M.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1171-5. doi: 10.1136/jnnp-2012-304850. Epub 2013 Apr 17.

PMID:
23595947
31.

Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.

Higuma M, Sanjo N, Satoh K, Shiga Y, Sakai K, Nozaki I, Hamaguchi T, Nakamura Y, Kitamoto T, Shirabe S, Murayama S, Yamada M, Tateishi J, Mizusawa H.

PLoS One. 2013;8(3):e60003. doi: 10.1371/journal.pone.0060003. Epub 2013 Mar 28.

32.

Tacrolimus monotherapy: a promising option for ocular myasthenia gravis.

Yagi Y, Sanjo N, Yokota T, Mizusawa H.

Eur Neurol. 2013;69(6):344-5. doi: 10.1159/000347068. Epub 2013 Mar 19. No abstract available.

33.

Visual reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer's disease in Japanese patients with mild cognitive impairments.

Hori T, Sanjo N, Tomita M, Mizusawa H.

Dement Geriatr Cogn Disord. 2013;35(3-4):165-76. doi: 10.1159/000346738. Epub 2013 Feb 8.

PMID:
23406667
34.

Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay.

Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, Sanjo N, Murai H, Mizusawa H, Schmitz M, Zerr I, Kim YS, Nishida N.

PLoS One. 2013;8(1):e54915. doi: 10.1371/journal.pone.0054915. Epub 2013 Jan 25.

35.

Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.

Kobayashi Z, Akaza M, Numasawa Y, Ishihara S, Tomimitsu H, Nakamichi K, Saijo M, Morio T, Shimizu N, Sanjo N, Shintani S, Mizusawa H.

J Neurol Sci. 2013 Jan 15;324(1-2):190-4. doi: 10.1016/j.jns.2012.11.004. Epub 2012 Nov 22.

PMID:
23182496
36.

[Case report; a case of chronic progressive neuro-Behcet's disease with extensive brain atrophy].

Higashi M, Sanjo N, Murayama S, Ota K, Sugita S, Yokota T, Mizusawa H.

Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3618-21. Japanese. No abstract available.

PMID:
22338892
37.

Multicentre multiobserver study of diffusion-weighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt-Jakob disease: a reliability and agreement study.

Fujita K, Harada M, Sasaki M, Yuasa T, Sakai K, Hamaguchi T, Sanjo N, Shiga Y, Satoh K, Atarashi R, Shirabe S, Nagata K, Maeda T, Murayama S, Izumi Y, Kaji R, Yamada M, Mizusawa H.

BMJ Open. 2012 Jan 30;2(1):e000649. doi: 10.1136/bmjopen-2011-000649. Print 2012.

38.

Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves.

Ohyagi M, Sanjo N, Yokota T, Mizusawa H.

J Neurol. 2012 May;259(5):977-9. doi: 10.1007/s00415-011-6287-3. Epub 2011 Oct 27. No abstract available.

PMID:
22037956
39.

Brainstem congestion due to carotid-cavernous fistula via a shunt from the external carotid artery.

Ito Y, Sanjo N, Ishikawa K, Tao O, Yokota T, Mizusawa H.

J Neurol. 2011 Dec;258(12):2288-90. doi: 10.1007/s00415-011-6102-1. Epub 2011 May 24. No abstract available.

PMID:
21607720
40.

[Rapid progressive HTLV-1-associated myelopathy with bronchoalveolar lesions and a long spinal cord lesion extending to almost the entire spinal cord].

Itami R, Sanjo N, Kuwahara H, Yamamoto M, Atarashi K, Yokota T, Mizusawa H.

Rinsho Shinkeigaku. 2011 Feb;51(2):130-4. Japanese.

PMID:
21404614
41.

Prospective 10-year surveillance of human prion diseases in Japan.

Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M.

Brain. 2010 Oct;133(10):3043-57. doi: 10.1093/brain/awq216. Epub 2010 Sep 20.

PMID:
20855418
42.

Localization and trafficking of endogenous anterior pharynx-defective 1, a component of Alzheimer's disease related gamma-secretase.

Sanjo N, Katayama T, Hasegawa H, Jin H, Duthie M, Mount HT, Mizusawa H, St George-Hyslop P, Fraser PE.

Neurosci Lett. 2010 Oct 8;483(1):53-6. doi: 10.1016/j.neulet.2010.07.061. Epub 2010 Jul 30.

PMID:
20674680
43.

[Prion disease--the characteristics and diagnostic points in Japan].

Sanjo N, Mizusawa H.

Rinsho Shinkeigaku. 2010 May;50(5):287-300. Review. Japanese.

PMID:
20535976
44.

Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calcium-ATPase and confers resistance to endoplasmic reticulum stress.

Jin H, Sanjo N, Uchihara T, Watabe K, St George-Hyslop P, Fraser PE, Mizusawa H.

J Alzheimers Dis. 2010;20(1):261-73. doi: 10.3233/JAD-2010-1360.

PMID:
20164584
45.

[Malignant lymphoma presented as left trigeminal neuralgia].

Akaza M, Tsunemi T, Sanjo N, Wakimoto H, Kobayashi D, Mizusawa H.

Rinsho Shinkeigaku. 2009 Jul;49(7):432-6. Review. Japanese.

PMID:
19715173
46.

[Acquired Creutzfeldt-Jakob disease (CJD)--Kuru, iatrogenic CJD, variant CJD].

Sanjo N.

Nihon Rinsho. 2007 Aug;65(8):1438-45. Review. Japanese.

PMID:
17695281
47.

TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity.

Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, Gu Y, Sanjo N, Glista M, Rogaeva E, Wakutani Y, Pardossi-Piquard R, Ruan X, Tandon A, Checler F, Marambaud P, Hansen K, Westaway D, St George-Hyslop P, Fraser P.

Nature. 2006 Apr 27;440(7088):1208-12.

PMID:
16641999
48.

Transient abundance of presenilin 1 fragments/nicastrin complex associated with synaptogenesis during development in rat cerebellum.

Uchihara T, Sanjo N, Nakamura A, Han K, Song SY, St George-Hyslop P, Fraser PE.

Neurobiol Aging. 2006 Jan;27(1):88-97. Epub 2005 Mar 31.

PMID:
16298244
49.

Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.

Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A.

J Biol Chem. 2005 Oct 7;280(40):34025-32. Epub 2005 Aug 2.

50.

Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes.

Hasegawa H, Sanjo N, Chen F, Gu YJ, Shier C, Petit A, Kawarai T, Katayama T, Schmidt SD, Mathews PM, Schmitt-Ulms G, Fraser PE, St George-Hyslop P.

J Biol Chem. 2004 Nov 5;279(45):46455-63. Epub 2004 Aug 17.

Supplemental Content

Support Center